AAAAAA

   
Results: 1-10 |
Results: 10

Authors: Brada, M Hoang-Xuan, K Rampling, R Dietrich, PY Dirix, LY Macdonald, D Heimans, JJ Zonnenberg, BA Bravo-Marques, JM Henriksson, R Stupp, R Yue, N Bruner, J Dugan, M Rao, S Zaknoen, S
Citation: M. Brada et al., Multicenter phase II trial of temozolomide in patients with glioblastoma multiforme at first relapse, ANN ONCOL, 12(2), 2001, pp. 259-266

Authors: Vermeulen, PB Colpaert, C Salgado, R Royers, R Hellemans, H Van den Heuvel, E Goovaerts, G Dirix, LY Van Marck, E
Citation: Pb. Vermeulen et al., Liver metastases from colorectal adenocarcinomas grow in three patterns with different angiogenesis and desmoplasia, J PATHOLOGY, 195(3), 2001, pp. 336-342

Authors: Kvinnsland, S Anker, G Dirix, LY Bonneterre, J Prove, AM Wilking, N Lobelle, JP Mariani, O di Salle, E Polli, A Massimini, G
Citation: S. Kvinnsland et al., High activity and tolerability demonstrated for exemestane in postmenopausal women with metastatic breast cancer who had previously failed on tamoxifen treatment, EUR J CANC, 36(8), 2000, pp. 976-982

Authors: Kaufmann, M Bajetta, E Dirix, LY Fein, LE Jones, SE Cervek, J Fowst, C Polli, A Di Salle, E Massimini, G Piscitelli, G
Citation: M. Kaufmann et al., Exemestane improves survival compared with megoestrol acetate in postmenopausal patients with advanced breast cancer who have failed on tamoxifen: results of a double-blind randomised phase III trial, EUR J CANC, 36, 2000, pp. S86-S87

Authors: Kaufmann, M Bajetta, E Dirix, LY Fein, LE Jones, SE Zilembo, N Dugardyn, JC Nasurdi, C Mennel, RG Cervek, J Fowst, C Polli, A di Salle, E Arkhipov, A Piscitelli, G Miller, LL Massimini, G
Citation: M. Kaufmann et al., Exemestane is superior to megestrol acetate after tamoxifen failure in postmenopausal women with advanced breast cancer: Results of a phase III randomized double-blind trial, J CL ONCOL, 18(7), 2000, pp. 1399-1411

Authors: Salgado, R Benoy, I Weytjens, R Vermeulen, PB Dirix, LY
Citation: R. Salgado et al., Serum vascular endothelial growth factor load and interleukin-6 in cancer patients - reply, BR J CANC, 82(11), 2000, pp. 1896-1896

Authors: Gasparini, G Toi, M Miceli, R Vermeulen, PB Dittadi, R Biganzoli, E Morabito, A Fanelli, M Gatti, C Suzuki, H Tominaga, T Dirix, LY Gion, M
Citation: G. Gasparini et al., Clinical relevance of vascular endothelial growth factor and thymidine phosphorylase in patients with node-positive breast cancer treated with eitheradjuvant chemotherapy or hormone therapy, CA J SCI AM, 5(2), 1999, pp. 101-111

Authors: Salgado, R Vermeulen, PB Benoy, I Weytjens, R Huget, P Van Marck, E Dirix, LY
Citation: R. Salgado et al., Platelet number and interleukin-6 correlate with VEGF but not with bFGF serum levels of advanced cancer patients, BR J CANC, 80(5-6), 1999, pp. 892-897

Authors: Vermeulen, PB Van den Eynden, GG Huget, P Goovaerts, G Weyler, J Lardon, F Van Marck, E Hubens, G Dirix, LY
Citation: Pb. Vermeulen et al., Prospective study of intratumoral microvessel density, p53 expression and survival in colorectal cancer, BR J CANC, 79(2), 1999, pp. 316-322

Authors: Vermeulen, PB Salven, P Benoy, I Gasparini, G Dirix, LY
Citation: Pb. Vermeulen et al., Blood platelets and serum VEGF in cancer patients, BR J CANC, 79(2), 1999, pp. 370-371
Risultati: 1-10 |